Open Orphan PLC (LSE: ORPH) has recently extended a contract with a top-three global pharma company. Its Venn Life Services subsidiary, operating out of Breda, Netherlands, will provide chemistry, manufacturing, and control consultancy services to support the client’s...
Open Orphan (LSE: ORPH) subsidiary Venn Life Sciences has extended a consulting contract with a global pharma firm to support two vaccine development programmes. Venn’s Breda office in the Netherlands will handle chemistry, manufacturing and control duties for the...
Human challenge study pioneer and AIM darling Open Orphan (LSE:ORPH) is set for a record-breaking 2021. The joint London and Dublin-listed pharma services firm is now profitable for the first time and it generating large amounts of cash. It’s been some...
Open Orphan’s (LSE:ORPH) strong run continued on Monday morning with the news that it has won two new contracts bolstering its presence in the global fight against coronavirus. The pharmaceutical services company said the first contract awarded to its subsidiary Venn...
Open Orphan (LSE:ORPH) Tuesday saw pharmaceutical services player Open Orphan (LSE:ORPH) announce the appointment of Elaine Sullivan as a non-executive director to its board. Sullivan is business leader with senior start-up experience, having been a founder of Carrick...
